SCHEMBL1476972

SCHEMBL1476972

C=C(C)C(=O)OC.C=C(C=CC(=O)O)C(=O)OC

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
HCAR2 Q8TDS4 5/20 0.45
ALOX15 P16050 2/20 0.38
RECQL P46063 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TDP1 Q9NUW8 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 4/20 0.36
TP53 P04637 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
EGLN3 Q9H6Z9 1/20 0.36
GAA P10253 1/20 0.32
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methacrylic Acid SCHEMBL3104275 0.92 ALDH1A1 (0.48) ALDH1A1HCAR2ALOX15RECQLHSD17B10
SCHEMBL4611870 0.92 HCAR2 (0.48) ALDH1A1HCAR2ALOX15RECQLHSD17B10
SCHEMBL36949 0.92 HCAR2 (0.52) ALDH1A1HCAR2ALOX15RECQLHSD17B10
Maleic Acid SCHEMBL8629341 0.92 ALDH1A1 (0.71) ALDH1A1HCAR2ALOX15RECQLHSD17B10
Fumaric Acid SCHEMBL10815593 0.92 ALDH1A1 (0.71) ALDH1A1HCAR2ALOX15RECQLHSD17B10
Fumaric Acid SCHEMBL10776632 0.92 ALDH1A1 (0.71) ALDH1A1HCAR2ALOX15RECQLHSD17B10
SCHEMBL770780 0.86 ALDH1A1 (0.48) ALDH1A1HCAR2MAPTTSHREGLN1
1,1-Dichloroethene SCHEMBL3943128 0.86 HCAR2 (0.46) ALDH1A1HCAR2ALOX15RECQLHSD17B10
Acrylic Acid SCHEMBL4839392 0.86 HCAR2 (0.46) ALDH1A1HCAR2ALOX15RECQLHSD17B10
1,1-Dichloroethene SCHEMBL5586489 0.84 ALDH1A1 (0.43) ALDH1A1HCAR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239193-B1 NONIONIC POLYETHOXYLATED SURFACTANT, AND WHICH SURFACTANT POSSESSES AN HLB VALUE OF FROM ABOUT 16.5 TO ABOUT 21 XEROX CORPORATION 2001-05-29 US claimed
US-7915347-B2 Block polymers and cosmetic compositions and processes comprising them L'OREAL S.A. (FR) 2011-03-29 US disclosed
EP-1518534-B1 Bilayered cosmetic product, uses thereof and kit-of-parts containing this product. OREAL (FR) 2010-07-14 EP disclosed
US-20080014234-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them L'OREAL 2008-01-17 US disclosed
US-20060134032-A1 Nail varnish composition comprising a sequenced polymer L'OREAL S.A. (FR) 2006-06-22 US disclosed
US-20060115444-A1 Glossy liquid composition comprising a sequenced polymer FUJIFILM CORPORATION (JP) 2006-06-01 US disclosed
WO-2005030155-A1 CONTINUOUS AQUEOUS PHASE-BASED PHOTOPROTECTIVE COMPOSITION CONTAINING A POLYMER COMPRISING AT LEAST TWO BLOCKS INCOMPATIBLE WITH EACH OTHER AND HAVING DIFFERENT GLASS TRANSITION TEMPERATURES L'ORÉAL (FR) 2005-04-07 WO disclosed
EP-1518534-A2 Bilayered cosmetic product, uses thereof and kit-of-parts containing this product. L'OREAL (FR) 2005-03-30 EP disclosed
US-6239193-B1 NONIONIC POLYETHOXYLATED SURFACTANT, AND WHICH SURFACTANT POSSESSES AN HLB VALUE OF FROM ABOUT 16.5 TO ABOUT 21 XEROX CORPORATION 2001-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060134032-A1 Nail varnish composition comprising a sequenced polymer POLR1C, DPM1, NACA ALDH1A1 3491/4885HCAR2 4872/4885ALOX15 3621/4885
US-20080014234-A1 Novel Block Polymers and Cosmetic Compositions and Processes Comprising Them FANCI, GDI2, TBCB ALDH1A1 1656/4885HCAR2 3597/4885ALOX15 1790/4885
US-20060115444-A1 Glossy liquid composition comprising a sequenced polymer CUTA, EPM2A, GRN ALDH1A1 3055/4885HCAR2 4635/4885ALOX15 1089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.